This inventor holds 3 USPTO granted patents. Top assignee: Innovir Laboratories, Inc.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: The Innovations of Andy Shih
Introduction
Andy Shih is a notable inventor based in New York, NY (US). He has made significant contributions to the field of RNA technology, holding a total of 3 patents. His work focuses on regulatable RNA molecules, which have the potential to revolutionize therapeutic approaches.
Latest Patents
Among his latest patents is the invention of regulatable RNA molecules. These molecules include regulatable ribozymes and nucleic acids that encode them. The technology involves a ligand-binding RNA sequence and a ribozyme sequence capable of cleaving a targeted RNA sequence. Upon binding of the ligand, the activity of the ribozyme sequence is altered, allowing for precise regulation of RNA activity. Additionally, he has developed regulatable mRNA molecules that can change translation upon ligand binding, showcasing the versatility of his innovations.
Career Highlights
Andy Shih is currently associated with Innovir Laboratories, Inc., where he continues to advance his research in RNA technology. His work has garnered attention for its potential applications in therapeutics and molecular biology.
Collaborations
He collaborates with talented individuals such as Jeffrey Michael Bockman and Shaji T George, contributing to a dynamic research environment.
Conclusion
Andy Shih's innovative work in regulatable RNA molecules positions him as a key figure in the field of biotechnology. His patents reflect a commitment to advancing scientific knowledge and therapeutic possibilities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile